Furthermore, measuring the mRNA levels of the SPDEF or ZBTB46 genes in blood samples or their protein expressions using biopsies from PCa patients by IHC staining could help in tracking the progression of PCa from primary to CRPC or monitoring the efficiency of treatment with ADT. This evidence concerns the gene SPDEF and posterior cortical atrophy.